U.S. Markets open in 24 mins.

Rigel Pharmaceuticals, Inc. (RIGL)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
2.81-0.03 (-1.06%)
At close: 4:00PM EDT

2.81 0.00 (0.00%)
Pre-Market: 8:22AM EDT

People also watch
ARRYPGNXPTIESPPINBIX
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue20,38328,8958,250
Cost of Revenue--9,302
Gross Profit20,38328,895-1,052
Operating Expenses
Research Development63,44662,82567,696
Selling General and Administrative20,90817,81322,501
Non Recurring5,7705,7705,770
Others---
Total Operating Expenses---
Operating Income or Loss-69,741-51,743-91,249
Income from Continuing Operations
Total Other Income/Expenses Net525279341
Earnings Before Interest and Taxes-69,216-51,464-90,908
Interest Expense---
Income Before Tax-69,216-51,464-90,908
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-69,216-51,464-90,908
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-69,216-51,464-90,908
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-69,216-51,464-90,908